[Recent advance in experimental study of cerebral ischemia treated by vascular endothelial growth factor]
- PMID: 15782506
[Recent advance in experimental study of cerebral ischemia treated by vascular endothelial growth factor]
Abstract
Vascular endothelial growth factor (VEGF) has been found to be the most powerful angiogenic factor. Studies have shown that cerebral ischemia and hypoxia stimulate the expressions of VEGF and its receptors in the brain, while exogenous VEGF promotes the formation of new blood vessels in the ischemic brain penumbra, and reduce the volume of cerebral infarction. The effect of VEGF on cerebral ischemia was previously explained the mechanism that VEGF had a specific mitogenetic roles in cerebral endothelial cells and thus promoted neovascularization; however recent evidence has shown that VEGF also has direct effects on neural and glial cells. Its multiple protection roles on central nervous system involve vascularization, neurogenesis, direct neurotrophic and neuroprotective effect, as well as antiapoptosis effect, especially when brain ischemia occurs. Further elucidation of these mechanisms on central nervous system may serve as a key procedure in understanding the main aspects of neural repair and neural protection, and develop effective therapeutic measures for intervention in stroke.
Similar articles
-
VEGF protects brain against focal ischemia without increasing blood--brain permeability when administered intracerebroventricularly.J Cereb Blood Flow Metab. 2005 Sep;25(9):1111-8. doi: 10.1038/sj.jcbfm.9600109. J Cereb Blood Flow Metab. 2005. PMID: 15829918
-
Contraindications of VEGF-based therapeutic angiogenesis: effects on macrophage density and histology of normal and ischemic brains.Vascul Pharmacol. 2006 May;44(5):316-25. doi: 10.1016/j.vph.2006.01.008. Epub 2006 Mar 10. Vascul Pharmacol. 2006. PMID: 16530019
-
Vascular endothelial growth factor improves recovery of sensorimotor and cognitive deficits after focal cerebral ischemia in the rat.Brain Res. 2006 Oct 18;1115(1):186-93. doi: 10.1016/j.brainres.2006.07.060. Epub 2006 Aug 22. Brain Res. 2006. PMID: 16928361
-
[Advances of study on the relationship between vascular endothelial growth factor and ischemic cerebral vascular disease].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2005 Apr;22(2):420-3. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2005. PMID: 15884570 Review. Chinese.
-
Vascular endothelial growth factor in cerebral ischemia.J Neurosci Res. 2011 Jul;89(7):969-78. doi: 10.1002/jnr.22628. Epub 2011 Apr 5. J Neurosci Res. 2011. Retraction in: J Neurosci Res. 2012 Jun;90(6):1296. doi: 10.1002/jnr.23043. PMID: 21469168 Retracted. Review.
Cited by
-
13-Methyltetradecanoic acid mitigates cerebral ischemia/reperfusion injury.Neural Regen Res. 2016 Sep;11(9):1431-1437. doi: 10.4103/1673-5374.191216. Neural Regen Res. 2016. PMID: 27857745 Free PMC article.
-
MMP-2 Is Mainly Expressed in Arterioles and Contributes to Cerebral Vascular Remodeling Associated with TGF-β1 Signaling.J Mol Neurosci. 2016 Jul;59(3):317-25. doi: 10.1007/s12031-015-0687-2. Epub 2015 Nov 21. J Mol Neurosci. 2016. PMID: 26590999